Proxima Secures $80M to Power AI-Driven Cancer and Immunology Therapies
AI-native biotech Proxima raised $80 million in an oversubscribed seed round to develop proximity-based therapeutics. The funding supports AI-driven discovery for previously “undruggable” targets across oncology and immunology.